Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

NCT04428554 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
130
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institut Claudius Regaud